9-Fmoc-aminoxanthen-3-yloxy polystyrene resin
Need Assistance?
  • US & Canada:
    +
  • UK: +

9-Fmoc-aminoxanthen-3-yloxy polystyrene resin

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

9-Fmoc-aminoxanthen-3-yloxy polystyrene resin is an excellent resin for the synthesis of protected peptide amides and carboxamides.

Category
Other Resins
Catalog number
BAT-000238
CAS number
915706-90-0
Molecular Formula
C36H29NO4
Molecular Weight
539.6
9-Fmoc-aminoxanthen-3-yloxy polystyrene resin
IUPAC Name
9H-fluoren-9-ylmethyl N-[3-[(4-methylphenyl)methoxy]-9H-xanthen-9-yl]carbamate
Synonyms
Sieber resin; Sieber amide resin
Appearance
Pale white or slight yellow beads
Purity
100-200 mesh,1% DVB,0.3-0.8mmol/g
DVB Crosslinking
1% DVB
Mesh Size
100-200 mesh
Substitution
0.6-0.8 meq/g
Storage
Store at 2-8°C
Solubility
None
InChI
InChI=1S/C36H29NO4/c1-23-14-16-24(17-15-23)21-39-25-18-19-31-34(20-25)41-33-13-7-6-12-30(33)35(31)37-36(38)40-22-32-28-10-4-2-8-26(28)27-9-3-5-11-29(27)32/h2-20,32,35H,21-22H2,1H3,(H,37,38)
InChI Key
RDRBIXSNGAYLPT-UHFFFAOYSA-N
Canonical SMILES
CC1=CC=C(C=C1)COC2=CC3=C(C=C2)C(C4=CC=CC=C4O3)NC(=O)OCC5C6=CC=CC=C6C7=CC=CC=C57
1. Properties of solid supports
M Meldal Methods Enzymol. 1997;289:83-104. doi: 10.1016/s0076-6879(97)89045-3.
Many supports including composite materials and functionalized surfaces are available for solid-phase synthesis. In the process of selecting the proper support it is important to consider the optimal performance during solid-phase synthesis. For most purposes the mechanically stable beaded gel resins are preferred. These resins are homogeneous, and the loading and physical and chemical properties can easily be varied. Optimal properties have been obtained by radical polymerization of end group acryloylated long-chain polyethylene glycols. However, polystyrene resins or amide bond free PEG-based resins may be more suited for general organic synthesis where reactivity of radicals, carbenes, carbanions, carbenium ions, or strong Lewis acids have to be considered. Loading of the resins can have a dramatic effect on the outcome of a synthesis and has to be considered separately for each synthesis. Synthesis of long peptides with 50-100 amino acids imposes completely different requirements on the performance, swelling, and loading than a large-scale synthesis of, for example, the pentapeptide enkephalin. Automated multiple synthesizers constructed for columns of beaded gel or composite supports are available from many suppliers. It is therefore expected that the optimization of support properties will continue in order to meet new synthetic challenges. In the synthesis for solid-phase screening of binding of biomolecules to ligands directly on the resin beads, it is an advantage if the resin is not permeable to the biomolecule so unbound molecules can easily be removed by washing. This is the case with polystyrene-based resins, but they do, however, often show nonspecific adhesion of proteins owing to the hydrophobic character of the polystyrene. Modification of the functional groups of polystyrene with polyethylene glycol as spacers for synthesis of the binding ligands can increase the available ligand concentration on the bead surface and eliminate most of the nonspecific adhesion. In contrast to binding studies, solid-phase assays of enzymes require beads that are permeable to the enzyme, as the progress of reaction can be followed and the product of reaction analyzed. The available amount on the surface of the polystyrene-based beads (approximately 0.3%) is not enough for product analysis. Therefore, in the case of enzyme assays, highly swelling permeable PEG-based gel resins or functionalized surfaces of a polar and porous matrix are preferred.
2. "Clickable" polymersomes
Joost A Opsteen, René P Brinkhuis, Rosalie L M Teeuwen, Dennis W P M Löwik, Jan C M van Hest Chem Commun (Camb). 2007 Aug 14;(30):3136-8. doi: 10.1039/b704568a. Epub 2007 Apr 27.
Polymersomes, composed of amphiphilic polystyrene-block-poly(acrylic acid) (PS-b-PAA), with the periphery being covered with azide groups, were used for further functionalization using "click" chemistry.
3. Dispelling myths and misconceptions about the treatment of acute hyperkalemia
Arnav A Gupta, Michael Self, Matthew Mueller, Gabriel Wardi, Christopher Tainter Am J Emerg Med. 2022 Feb;52:85-91. doi: 10.1016/j.ajem.2021.11.030. Epub 2021 Nov 27.
Hyperkalemia represents a widespread and potentially lethal condition that affects millions of people across their lives. Despite the prevalence and severity of the condition, there are no consensus guidelines on the treatment of hyperkalemia or even a standard definition. Herein, we provide a succinct review of what we believe to be the most significant misconceptions encountered in the emergency care of hyperkalemia, examine current available literature, and discuss practical points on several modalities of hyperkalemia treatment. Additionally, we review the pathophysiology of the electrocardiographic effects of hyperkalemia and how intravenous calcium preparations can antagonize these effects. We conclude each section with recommendations to aid emergency physicians in making safe and efficacious choices for the treatment of acute hyperkalemia.
Online Inquiry
Verification code
Inquiry Basket